| Revenue growth | 32% YoY growth to ₹110.7 crore in FY26. |
|---|---|
| Margins | EBITDA margins expanded significantly to 20.4%. |
| Demand visibility | Strong traction in textiles and high growth in home/personal care. |
| Management confidence | Optimistic, highlighting successful brand transition and specialty chemical scaling. |
Growth
Revenue grew 32% YoY to ₹110.7 crore, while EBITDA margins jumped 321 bps to 20.4% due to better product mix.
Outlook
Targeting ₹250 crore revenue by FY28 at 85% capacity utilization with 18-20% EBITDA margins.
Risks
High receivables (161 days) and geopolitical volatility affecting raw material costs and Bangladesh exports remain key concerns.
Earnings Call filed with NSE, NSE: NEOCHEM. Summary written with AI assistance from the document.
Neochem Bio Solutions Ltd: key numbers
- Share price
- ₹106.20
- Market cap
- ₹181.8 Cr
- Revenue (annual)
- ₹110.7 Cr
- Net profit (annual)
- ₹12.03 Cr
- P/E (TTM)
- 15.1×Sector 37.5×
- Promoter holding
- 66.72%
- FII holding
- 0.18%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Neochem Bio Solutions Ltd
All →Neochem Bio Solutions Annual General Meeting
Neochem Bio Solutions Limited held its 9th Annual General Meeting on September 21, 2026, where management reviewed the company's performance and discussed future business strategies.
Neochem Bio Solutions Promoter Buying: ₹0.14 Cr
Promoter Swapnil R. Makati acquired 1,200 equity shares of Neochem Bio Solutions Limited for ₹0.14 Crore via an on-market purchase.
- Value
- ₹0.14 Cr
- Promoter stake change
- +0.01%
Neochem Bio Solutions Promoter Buying: ₹0.07 Cr
Promoter and MD Swapnil Makati purchased 7,200 Neochem Bio Solutions shares on NSE for ₹0.07 Crore. His stake rose from 54.70% to 54.74%.
- Value
- ₹0.07 Cr
- Promoter stake change
- +0.04%
Neochem Bio Solutions Earnings Call: Key Takeaways
Neochem Bio Solutions reported FY26 revenue of ₹110.7 Cr (+32% YoY) and PAT of ₹12.0 Cr (+62% YoY), driven by specialty chemical demand and segment diversification into home and personal care.
Neochem Bio Solutions Earnings Call: Key Takeaways
Neochem Bio Solutions delivered strong FY26 results with 32% revenue growth and 53% EBITDA growth, driven by a shift to own-brand performance chemicals and expansion into HPC and paints.
Neochem Bio Solutions Earnings Call: Key Takeaways
Neochem Bio Solutions Limited reported FY26 Total Income of ₹113.4cr, reflecting 32% YoY growth. Strategy focuses on diversifying from textile into HPC and industrial specialty chemicals.